Improving blood glucose control with a lunch-time dose of regular insulin in diabetic patients on twice daily mixed insuli

Not Applicable

• Conditions: Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: PACTR201610001812290
• Lead Sponsor: Borg El-Arab Hospital, Ministry of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-06
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Receiving twice daily insulin only
Have access to a nearby pharmacy or a healthcare unit
Have access to a phone
Baseline HbA1c% of 8 or above

Exclusion Criteria

History of severe hyperglycemia, high risk of hyperglycemia and/or hyperglycemia unawareness
Renal and hepatic patients
Patients with uncontrolled ischemic heart disease
Patients on beta-blockers, glucocorticoids, insulin secretagogues
Pregnant and lactating women

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
owering HbA1c% to below 7

Secondary Outcome Measures

Name	Time	Method
Reduction of the progression of diabetic nephropathy measured as albumin/creatinine ratio;Assessment on changed insulin ordering patterns and insulin shortages